Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Batavia Biosciences
Batavia Biosciences
Activities:
Manufacturing
Regulatory
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
N4 Pharma and SRI to target and treat previously unreachable human cells
The companies will collaborate to perform research to conjugate SRI’s MGS system to Nuvec to increase intracellular delivery to specific target cells.
Berry Global invests to increase production capacity for healthcare products
Berry Global Group has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites
Innovation in generics: increased efficiency through peptide API synthesis expertise
Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
Batavia enters the commercial manufacturing business
Batavia Biosciences is set to extend its CDMO services portfolio (R&D and clinical manufacturing) to include commercial manufacturing services
Manufacturing
Global alliance chooses Horizon Discovery cell line for Zika antibody
Batavia Biosciences, Vanderbilt University Medical Center (VUMC) and IDBiologics will use the cell line expression system to produce and antibody for the potent virus
Pharmaceutical
Univercells launches new vaccine manufacturing platform
Low-cost vaccine manufacturing technology, NevoLine, has been launched and already received grant for scale-up
Research & Development
Batavia partners with IAVI to advance development of vaccine against Lassa fever
The International AIDS Vaccine Initiative (IAVI) and Batavia Biosciences will work together under a grant to advance the development of a Lassa fever vaccine
Research & Development
Batavia Biosciences receives $8 million grant to develop rotavirus vaccine
Will develop a low-cost manufacturing process using novel technologies in partnership with Bio Farma
Subscribe now